BeOne Medicines (ONC) Treasury Shares (2015 - 2018)
BeOne Medicines' (ONC) quarterly Treasury Shares came in at $300000.0 in Q4 2018, down 79.58% year-on-year from $1.5 million in Q4 2017, and down 43.17% on a QoQ basis from $527904.0 in Q2 2018.
BeOne Medicines (ONC) Treasury Shares (2015 - 2018) Analysis & Trends
BeOne Medicines (ONC) has 3 years of Treasury Shares data on file, last reported at $300000.0 in Q4 2018.
- On a quarterly basis, Treasury Shares fell 79.58% year-over-year to $300000.0 in Q4 2018; TTM through Dec 2018 was $300000.0, a 79.58% decrease from a year earlier, with the FY2018 full-year figure at $300000.0, down 79.58% from the prior year.
- Treasury Shares for Q4 2018 stood at $300000.0, down from $527904.0 in the prior quarter.
- Over the last five years, Treasury Shares for ONC reached as high as $4.1 million in Q1 2018 and fell as low as $44445.0 in Q4 2015.
- Historically, Treasury Shares has averaged $1.3 million across 3 years, with a median of $870157.5 in 2017.
- On a YoY basis, Treasury Shares climbed as much as 79.58% in 2018 and fell as far as 79.58% in 2018.
- Year by year, Treasury Shares stood at $44445.0 in 2015, then surged by 3206.2% to $1.5 million in 2017, then tumbled by 79.58% to $300000.0 in 2018.
- Per Business Quant data, the three most recent Treasury Shares figures were $300000.0 in Q4 2018, $527904.0 in Q2 2018, and $4.1 million in Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 34.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 5.14 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 300,000.00 |
| Dec 31, 2018 | 300,000.00 |
| Jun 30, 2018 | 527,904.00 |
| Jun 30, 2018 | 527,904.00 |
| Mar 31, 2018 | 4.12 Mn |
| Mar 31, 2018 | 4.12 Mn |
| Dec 31, 2017 | 1.47 Mn |
| Dec 31, 2017 | 1.47 Mn |
| Sep 30, 2017 | 1.21 Mn |
| Sep 30, 2017 | 1.21 Mn |
| Dec 31, 2015 | 44,445.00 |
| Dec 31, 2015 | 44,445.00 |